Bright Minds Biosciences Inc. · CSE:DRUG
Adage Capital Management, L.P.'s stake in Bright Minds Biosciences Inc. fell to 3.41% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 12, 2026
Adage Capital Management, L.P.'s stake in Bright Minds Biosciences Inc. fell to 3.41%, 335,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 12, 2026 (Schedule 13G/A).
- Stake
- 3.41%
- Shares
- 335,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 3.41% | 335,000 |
| Robert Atchinson | 3.41% | 335,000 |
| Phillip Gross | 3.41% | 335,000 |
Source
Related
- Bright Minds Biosciences Inc.
- Adage Capital Management, L.P.
- Bright Minds Biosciences Inc. shareholders
- Schedule 13G · Adage Capital Management, L.P. · Nov 13, 2025
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13D/A · Ian McDonald · Jul 2, 2026
- Schedule 13G · Vestal Point Capital, LP · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026